|
||||||||||||||||
HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
PROTEIN EXPRESSION | ||||||||||||||||
December 06, 2000 | ||||||||||||||||
Cambridge Healthtech Institute, McLean, Virginia April 5-6, 2001 The vast number of candidate proteins generated from genomics programs is creating enormous opportunities for biologists. However, efficient and rapid expression of genes in homologous and heterologous expression systems and rapid purification steps are major bottlenecks. Advances in the technology to produce protein-based drugs efficiently as well as improved drug delivery strategies have accelerated the search for novel protein therapeutic candidates. However, the practical and cost-effective expression of these proteins in amounts large enough to allow for their proper characterization and evaluation and, finally, for the scale-up for large-scale production of these proteins presents many difficulties. This conference will explore the newest data and technologies relating to the science and expression of proteins for pharmaceuticals. |
||||||||||||||||
Organized by: | Cambridge Healthtech Institute | |||||||||||||||
Invited Speakers: | Dr. Patrick Farrell, University of Calgary (Canada) Dr. Alex Karavanov, Ciphergen Biosystems, Inc. Dr. David Waugh, National Cancer Institute, NIH Dr. Lynne Krummen, Genentech, Inc. Dr. Ashutosh Chilkoti, Duke University Dr. Robert B. Kirkpatrick, SmithKline Beecham Pharmaceuticals |
|||||||||||||||
Deadline for Abstracts: | March 2, 2001 | |||||||||||||||
Registration: | Available on-line | |||||||||||||||
E-mail: | jlaakso@healthtech.com | |||||||||||||||
Posted by: | Jennifer Laakso | |||||||||||||||
Host: | wks217.healthtech.com | |||||||||||||||
|
||||||||||||||||
Generated by meetings and positions 5.0 by Kai Garlipp |